Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
Key Highlights
- ➤Achieve appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
- ➤Tuson joins executive team ahead of potential cytisinicline commercialization
- ➤Achieve plans NDA resubmission for cytisinicline
- ➤Achieve secured financing of up to $354 million in 2026
Expert Statements
Andrew D. Goldberg, Chief Executive Officer of Achieve Life Sciences
“We are delighted to welcome Kait to Achieve at this important time. Her experience across brand building, product launch strategy, patient engagement, and health systems will be invaluable as we advance toward our planned NDA resubmission and prepare for the potential commercialization of cytisinicline.”
Andrew D. Goldberg, Chief Executive Officer of Achieve Life Sciences
“Kait will lead our efforts to build understanding of nicotine dependence as a treatable condition among patients, healthcare professionals, and other key stakeholders.”
Kaitlyn Tuson, Senior Vice President, Marketing and Communications of Achieve Life Sciences
“Smoking remains the leading cause of preventable death in the world, and the tools available to help people quit haven’t meaningfully changed in two decades.”
Kaitlyn Tuson, Senior Vice President, Marketing and Communications of Achieve Life Sciences
“I’ve spent my career building healthcare brands that turn science into something patients can act on, meeting them where they are and earning the trust of the clinicians who guide them.”
Kaitlyn Tuson, Senior Vice President, Marketing and Communications of Achieve Life Sciences
“I’m honored to bring that experience to Achieve at a moment when cytisinicline has the potential to change what’s possible for millions of people who want and need to quit smoking and vaping.”
SEATTLE and VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced the appointment of Kaitlyn (Kait) Tuson as Senior Vice President, Marketing and Communications. Tuson joins Achieve’s executive team and will lead its marketing, brand strategy, and corporate communications as the Company prepares for the potential commercialization of cytisinicline.
Tuson has spent 15 years building, launching, and scaling brands across the healthcare industry, with go-to-market leadership spanning dozens of launches, six of them in pharma, including three blockbuster therapies. She specializes in designing high-engagement, direct-to-patient experiences and has led campaigns, both for healthcare providers and consumers, from strategy through execution across more than 40 therapeutic areas and conditions globally.
Get started
Create a free account to read the full story.